<code id='8240571228'></code><style id='8240571228'></style>
    • <acronym id='8240571228'></acronym>
      <center id='8240571228'><center id='8240571228'><tfoot id='8240571228'></tfoot></center><abbr id='8240571228'><dir id='8240571228'><tfoot id='8240571228'></tfoot><noframes id='8240571228'>

    • <optgroup id='8240571228'><strike id='8240571228'><sup id='8240571228'></sup></strike><code id='8240571228'></code></optgroup>
        1. <b id='8240571228'><label id='8240571228'><select id='8240571228'><dt id='8240571228'><span id='8240571228'></span></dt></select></label></b><u id='8240571228'></u>
          <i id='8240571228'><strike id='8240571228'><tt id='8240571228'><pre id='8240571228'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:4172
          Bruce Broussard. -- health business coverage from STAT
          Humana CEO Bruce Broussard Jason DeCrow/AP

          Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

          Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

          advertisement

          Humana’s stock fell by more than 2% on the news Wednesday morning.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          FDA's Pazdur wants cancer trials to range beyond China alone
          FDA's Pazdur wants cancer trials to range beyond China alone

          RichardPazdur,right,alsospokeabouttheFDA'suseofacceleratedapproval.MeganBearderPhotographyCHICAGO— T

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Treeline, Josh Bilenker's next biotech, is cloaked in mystery

          APPhoto/TedS.WarrenJoshBilenker’slastcompany,LoxoOncology,waspurchasedbyEliLillyfor$8billion.Nosurpr